Compound ion salt, a novel low-sodium salt substitute: From animal study to community-based population trial

American Journal of Hypertension

Volumn 22, Issue 9, 2009, Pages 934-942

  Zhou, Xin ^a   Liu, Jun Xiang ^a   Shi, Rui ^a   Yang, Ning ^a   Song, Dong Lin ^a   Pang, Wei ^a   Li, Yu Ming ^a  

^a Pingjin Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; COMPOUND ION SALT; NITRIC OXIDE; SODIUM CHLORIDE; SODIUM DERIVATIVE; SODIUM ION; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROLYTE URINE LEVEL; FEMALE; FOLLOW UP; HEART; HUMAN; HYPERTENSION; KIDNEY CORTEX; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RAT; SALT INTAKE; SINGLE BLIND PROCEDURE; SODIUM RESTRICTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

AGED; AGED, 80 AND OVER; ANIMALS; BLOOD PRESSURE; CALCIUM CARBONATE; CALCIUM CITRATE; ELECTROLYTES; FEMALE; FOLIC ACID; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; MYOCARDIUM; POTASSIUM CHLORIDE; RATS; RATS, INBRED SHR; SODIUM CHLORIDE;

EID: 69249218855     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.135     Document Type: Conference Paper

References (36)

1. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressurerelated disease, 2001. Lancet 2008; 371:1513-1518.
2. Uhlenhaut NH, Treier M. Transcriptional regulators in kidney disease: gatekeepers of renal homeostasis. Trends Genet 2008; 24:361-371.
3. Himmelfarb J, Kliger AS. End-stage renal disease measures of quality. Annu Rev Med 2007; 58:387-399.
4. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25-146.
5. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85:679-715.
6. Adrogué HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007; 356:1966-1978.
7. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334:885.
8. Neaton JD, Grimm RH Jr., Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270:713-724.
9. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale for salt restriction and salt-restriction target level for the management of hypertension. Hypertens Res 2007; 30:879-886.
10. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002; 325:628.
11. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52:1749-1757.
12. The China Salt Substitute Study Collaborative Group. Salt substitution: a lowcost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens 2007; 25:2011-2018.
13. Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 1994; 89:397-410.
14. Bromage TG, Goldman HM, McFarlin SC, Warshaw J, Boyde A, Riggs CM. Circularly polarized light standards for investigations of collagen fiber orientation in bone. Anat Rec B New Anat 2003; 274:157-168.
15. Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S, Abe Y. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol 2004; 15:306-315.
16. Fujiwara T, Kawamura M, Nakajima J, Adachi T, Hiramori K. Seasonal differences in diurnal blood pressure of hypertensive patients living in a stable environmental temperature. J Hypertens 1995; 13:1747-1752.
17. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118:2679-2686.
18. Group ICR. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297:319-328.
19. Forte JG, Miguel JM, Miguel MJ, de Pádua F, Rose G. Salt and blood pressure: a community trial. J Hum Hypertens 1989; 3:179-184.
20. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003; 42:1093-1099.
21. Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 1997; 65:626S-642S.
22. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997; 277:1624-1632.
23. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117-1124.
24. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999; 159:285-293.
25. Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA, Mason J. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006; CD004639.
26. Heaney RP. Role of dietary sodium in osteoporosis. J Am Coll Nutr 2006; 25:271S-276S.
27. Teucher B, Fairweather-Tait S. Dietary sodium as a risk factor for osteoporosis: where is the evidence? Proc Nutr Soc 2003; 62:859-866.
28. O'Shaughnessy KM, Karet FE. Salt handling and hypertension. Annu Rev Nutr 2006; 26:343-365.
29. Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public-health challenge. Lancet 2006; 367:1352-1361.
30. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354:1567-1577.
31. Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol 2006; 47: 1108-1116.
32. Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygård O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008; 300:795-804.
33. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369:1876-1882.
34. Yang Q, Botto LD, Erickson JD, Berry RJ, Sambell C, Johansen H, Friedman JM. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006; 113:1335-1343.
35. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16:761-770.
36. Li N, Prescott J, Wu Y, Barzi F, Yu X, Zhao L, Neal B. The effects of a reducedsodium, high-potassium salt substitute on food taste and acceptability in rural northern China. Br J Nutr 2009; 101:1088-1093.